Avion Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Buy
305
+100
+49% +$4.3K ﹤0.01% 490
2026
Q1
$7K Buy
205
+105
+105% +$4.97K ﹤0.01% 585
2025
Q4
$5K Buy
+100
New +$5.11K ﹤0.01% 661
2023
Q2
Sell
-22
Closed -$1K 949
2023
Q1
$1K Buy
+22
New +$1.56K ﹤0.01% 468

Other funds holding NVO

Avion Wealth's NVO Position: Q2 2026 in Review

Avion Wealth increased its Novo Nordisk (NVO) stake by 49% in Q2 2026, buying an estimated $4.3K and bringing the position to 305 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Avion Wealth first reported a position in NVO in Q1 2023 and has held it in 4 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Avion Wealth held 305 shares of Novo Nordisk worth $14K as of Q2 2026.
  • Avion Wealth bought 100 Novo Nordisk shares in Q2 2026, an estimated $4.3K.
  • Novo Nordisk made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #490 holding.
  • Avion Wealth first reported a position in Novo Nordisk in Q1 2023 and has held it in 4 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.